Nevakar Pharmaceuticals, Inc.
PrivateLast Round
Debt
Oct 7, 2019
Total Funding Raised
$87.5M
Company Overview
Nevakar Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Bridgewater, New Jersey. Its latest recorded funding round was a Debt round in October 2019.
Nevakar Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops innovative ophthalmic and injectable products through drug repositioning and proprietary formulation enhancements.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nevakar Pharmaceuticals, Inc. Comparables
Compare Nevakar Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexus Pharmaceuticals | 85% | |
| Exela Pharma Sciences | 85% | |
| Sagent Pharmaceuticals | 81% |
For institutional investors. Book with your work email.
Nevakar Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 7, 2019 | ||||
| Debt | Jun 18, 2019 | ||||
| Debt | Nov 29, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nevakar Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NovaQuest Capital Management | Debt |
| Oxford Finance | Debt |
| H.I.G. Capital | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2019
$18M raised from H.I.G. Capital.
- Jun 18, 2019
$50M raised with NovaQuest Capital Management.
For institutional investors. Book with your work email.
Nevakar Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nevakar Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Nevakar Pharmaceuticals, Inc. a public or private company?
Nevakar Pharmaceuticals, Inc. is a private company.
What is the current stock price of Nevakar Pharmaceuticals, Inc.?
Nevakar Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Nevakar Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nevakar Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Nevakar Pharmaceuticals, Inc. is not publicly available.
Can I buy Nevakar Pharmaceuticals, Inc. stock?
Nevakar Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nevakar Pharmaceuticals, Inc.'s last funding round?
Nevakar Pharmaceuticals, Inc.'s most recent funding round was Debt on October 7, 2019.
Who are the main investors in Nevakar Pharmaceuticals, Inc.?
Key investors in Nevakar Pharmaceuticals, Inc. include NovaQuest Capital Management, Oxford Finance, H.I.G. Capital.
Will Nevakar Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Nevakar Pharmaceuticals, Inc..
How can I track Nevakar Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Nevakar Pharmaceuticals, Inc.'s shares on secondary markets.